- Home
- PPBT vs SQFT Comparison
PPBT vs SQFT Comparison
Compare PPBT & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- SQFT
- Stock Information
- Founded
- PPBT 2010
- SQFT 1999
- Country
- PPBT Israel
- SQFT United States
- Employees
- PPBT N/A
- SQFT N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- SQFT Real Estate Investment Trusts
- Sector
- PPBT Health Care
- SQFT Real Estate
- Exchange
- PPBT Nasdaq
- SQFT Nasdaq
- Market Cap
- PPBT 6.2M
- SQFT 6.2M
- IPO Year
- PPBT N/A
- SQFT 2020
- Fundamental
- Price
- PPBT $2.53
- SQFT $13.60
- Analyst Decision
- PPBT Strong Buy
- SQFT
- Analyst Count
- PPBT 1
- SQFT 0
- Target Price
- PPBT $33.00
- SQFT N/A
- AVG Volume (30 Days)
- PPBT 18.2K
- SQFT 2.5M
- Earning Date
- PPBT 08-15-2025
- SQFT 08-13-2025
- Dividend Yield
- PPBT N/A
- SQFT N/A
- EPS Growth
- PPBT N/A
- SQFT N/A
- EPS
- PPBT N/A
- SQFT N/A
- Revenue
- PPBT N/A
- SQFT $18,260,398.00
- Revenue This Year
- PPBT N/A
- SQFT $23.63
- Revenue Next Year
- PPBT N/A
- SQFT N/A
- P/E Ratio
- PPBT N/A
- SQFT N/A
- Revenue Growth
- PPBT N/A
- SQFT N/A
- 52 Week Low
- PPBT $2.00
- SQFT $4.19
- 52 Week High
- PPBT $13.95
- SQFT $23.00
- Technical
- Relative Strength Index (RSI)
- PPBT 56.04
- SQFT 89.22
- Support Level
- PPBT $2.35
- SQFT $4.55
- Resistance Level
- PPBT $2.58
- SQFT $5.77
- Average True Range (ATR)
- PPBT 0.12
- SQFT 1.35
- MACD
- PPBT 0.02
- SQFT 0.62
- Stochastic Oscillator
- PPBT 84.38
- SQFT 49.77
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.